Study Of Safety And Efficacy Of Ertugliflozin (PF-04971729, MK-8835) In Participants With Type 2 Diabetes (MK-8835-016)
Clinical trial NCT01059825 · COMPLETED
Trial details
- NCT number
- NCT01059825
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-02-24
- Primary completion
- 2011-01-20
- Enrollment
- 375
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.